| Literature DB >> 28418656 |
John M Sanders1, Douglas C Beshore1, J Christopher Culberson1, James I Fells1, Jason E Imbriglio1, Hakan Gunaydin1, Andrew M Haidle1, Marc Labroli1, Brian E Mattioni1, Nunzio Sciammetta1, William D Shipe1, Robert P Sheridan1, Linda M Suen1, Andreas Verras1, Abbas Walji1, Elizabeth M Joshi1, Tjerk Bueters1.
Abstract
High-throughput screening (HTS) has enabled millions of compounds to be assessed for biological activity, but challenges remain in the prioritization of hit series. While biological, absorption, distribution, metabolism, excretion, and toxicity (ADMET), purity, and structural data are routinely used to select chemical matter for further follow-up, the scarcity of historical ADMET data for screening hits limits our understanding of early hit compounds. Herein, we describe a process that utilizes a battery of in-house quantitative structure-activity relationship (QSAR) models to generate in silico ADMET profiles for hit series to enable more complete characterizations of HTS chemical matter. These profiles allow teams to quickly assess hit series for desirable ADMET properties or suspected liabilities that may require significant optimization. Accordingly, these in silico data can direct ADMET experimentation and profoundly impact the progression of hit series. Several prospective examples are presented to substantiate the value of this approach.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28418656 DOI: 10.1021/acs.jmedchem.6b01577
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446